Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital
- PMID: 32967718
- PMCID: PMC7513325
- DOI: 10.1186/s13756-020-00816-4
Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital
Abstract
Background: Nosocomial carbapenemase-producing Enterobacterieceae (CPE) infections constitute a major global health concern and are associated with increased morbidity and mortality. Rectal colonization with CPE is a risk factor for bacterial translocation leading to subsequent endogenous CPE infections. This prospective observational study was aimed to investigate the prevalence and epidemiology of rectal colonization of CPE, the carbapenemase genotypes, and to identify the independent risk factors for the acquisition of CPE colonization in high-risk patients from ICU and HSCT wards in a university hospital in China.
Methods: In a prospective cohort study, 150 fecal samples from rectal swabs were consecutively obtained for inpatients from the intensive care unit (ICU) and hematopoietic stem cell transplantation (HSCT) wards from November 2018 to May 2019, and screening test for CPE was conducted by using prepared in-house trypsin soybean broth (TSB) selective media and MacConkey agar. Antimicrobial susceptibility was determined by the broth microdilution method and carbapenemase genes were characterized by both the GeneXpert Carba-R and PCR for blaKPC, blaNDM, blaIMP, blaVIM and blaOXA. Multi-locus sequence typing (MLST) was employed to characterize the genetic relationships among the carbapenemase-producing K. Pneumonia (CPKP) isolates. In order to further investigate the risk factors and clinical outcomes of CPE colonization, a prospective case-control study was also performed.
Results: Twenty-six suspected CPE strains, including 17 Klebsiella pneumoniae, 6 Escherichia coli, 1 Citrobacter freundii, 1 Enterobacter Kobe, and 1 Raoultella ornithinolytica, were identified in 25 non-duplicated rectal swab samples from 25 patients, with a carriage rate of 16.67% (25/150). Through GeneXpert Carba-R and subsequent PCR and sequencing, all the suspected CPE isolates were identified to be positive for the carbapenemase genes, of which 17 were blaKPC-carriers, and another 9 were blaNDM-producers. MLST designated all the CPKP isolates to be ST11 clone. Multivariate analysis indicated that urinary system diseases, operation of bronchoscopy, and combined use of antibiotics were independent risk factors for acquiring CPE colonization in high-risk patients from the ICU and HSCT wards.
Conclusions: This study revealed a high prevalence of rectal CPE colonization in high-risk patients from ICU and HSCT wards, and a predominant colonization of the KPC-producing K. pneumoniae clone ST11. Stricter infection control measures are urgently needed to limit the dissemination of CPE strains, especially in patients who were afflicted by urinary system diseases, have underwent bronchoscopy, and were previously exposed to combined antibiotic use.
Keywords: CPE; CRE; Fecal carriage; KPC; Risk factors.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai.BMC Infect Dis. 2019 Aug 1;19(1):678. doi: 10.1186/s12879-019-4298-3. BMC Infect Dis. 2019. PMID: 31370804 Free PMC article.
-
Analysis of rectal carbapenem-resistant Enterobactericeae colonization results first report in Istanbul/Turkiye: Klebsiella pneumoniae co-producing blaKPC + blaNDM + blaOXA-48 in a single strain.BMC Infect Dis. 2025 May 29;25(1):773. doi: 10.1186/s12879-025-11111-1. BMC Infect Dis. 2025. PMID: 40442618 Free PMC article.
-
Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla NDM-7 and bla OXA-48.Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2127-2135. doi: 10.1007/s10096-017-3035-3. Epub 2017 Jun 21. Eur J Clin Microbiol Infect Dis. 2017. PMID: 28639165
-
Accuracy of Xpert Carba-R Assay for the Diagnosis of Carbapenemase-Producing Organisms from Rectal Swabs and Clinical Isolates: A Meta-Analysis of Diagnostic Studies.J Mol Diagn. 2021 Nov;23(11):1534-1544. doi: 10.1016/j.jmoldx.2021.08.006. Epub 2021 Aug 25. J Mol Diagn. 2021. PMID: 34454107
-
Emergence of Carbapenemaseproducing Klebsiella Pneumoniae of Sequence type 258 in Michigan, USA.Infect Dis Rep. 2013 Mar 19;5(1):e5. doi: 10.4081/idr.2013.e5. eCollection 2013 Jan 22. Infect Dis Rep. 2013. PMID: 24470956 Free PMC article. Review.
Cited by
-
Colonization with extended spectrum beta-lactamase and carbapenemases producing Enterobacteriaceae among hospitalized patients at the global level: A systematic review and meta-analysis.PLoS One. 2023 Nov 27;18(11):e0293528. doi: 10.1371/journal.pone.0293528. eCollection 2023. PLoS One. 2023. PMID: 38011148 Free PMC article.
-
A clinical predictive model for pre-transplantation Klebsiella pneumoniae colonization and relevance for clinical outcomes in patients receiving allogeneic hematopoietic stem cell transplantation.Microbiol Spectr. 2024 Feb 6;12(2):e0203923. doi: 10.1128/spectrum.02039-23. Epub 2024 Jan 8. Microbiol Spectr. 2024. PMID: 38189331 Free PMC article.
-
Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease.Ann Clin Microbiol Antimicrob. 2023 Jan 29;22(1):10. doi: 10.1186/s12941-023-00560-8. Ann Clin Microbiol Antimicrob. 2023. PMID: 36710337 Free PMC article.
-
Epidemiology and clinical characteristics of patients with carbapenem-resistant enterobacterales infections: experience from a large tertiary care center in a developing country.BMC Infect Dis. 2023 Oct 2;23(1):644. doi: 10.1186/s12879-023-08643-9. BMC Infect Dis. 2023. PMID: 37784023 Free PMC article.
-
Risk factors for carbapenem-resistant Enterobacterales infection among hospitalized patients with previous colonization.J Clin Lab Anal. 2022 Nov;36(11):e24715. doi: 10.1002/jcla.24715. Epub 2022 Sep 30. J Clin Lab Anal. 2022. PMID: 36181301 Free PMC article.
References
-
- Durante-Mangoni E, Andini R, Zampino R. Management of carbapenem resistant Enterobacteriaceae infections. Clin Microbiol Infect. 2019;25(8):943–950. - PubMed
-
- Righi E, Peri AM, Harris PN, Wailan AM, Liborio M, Lane SW, et al. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis. J Antimicrob Chemother. 2017;72(3):668–677. - PubMed
-
- World Health Organization . Essential medicines and health products. prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. Geneva, Switzerland: WHO; 2017.
-
- WHO . WHO publishes list of bacteria for which new antibiotics are urgently needed. WHO Media Centre. 2017. pp. 1–4.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous